Overview
Rodrigo Alcantara practices practicing medicine in Barcelona, Spain.
Mr. Alcantara is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Fibrocystic Breast Disease and Breast Cancer.
He is actively involved in clinical research, co-authoring 44 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rodrigo Alcantara
Is Rodrigo Alcantara a top-rated expert for Fibrocystic Breast Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Rodrigo Alcantara is classified as an Distinguished expert for Fibrocystic Breast Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rodrigo Alcantara participate in research or clinical trials?
Yes. Rodrigo Alcantara has published 44 articles and abstracts on conditions like Fibrocystic Breast Disease. You can view a list of Rodrigo Alcantara's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Fibrocystic Breast DiseaseMr. Alcantara isDistinguished. Learn about Fibrocystic Breast Disease.
- Advanced
- Breast CancerMr. Alcantara isAdvanced. Learn about Breast Cancer.